Conjunctivitis, Bacterial
Showing 1 - 25 of 4,181
Acute Bacterial Conjunctivitis Trial (IVIEW-1201, Ofloxacin Eye Drops)
Not yet recruiting
- Acute Bacterial Conjunctivitis
- IVIEW-1201
- Ofloxacin Eye Drops
- (no location specified)
Apr 13, 2023
Conjunctivitis, Bacterial Trial in Guadalajara, Aguascalientes, Mexico City (Pazufloxacin, Zymar)
Terminated
- Conjunctivitis, Bacterial
-
Guadalajara, Jalisco, Mexico
- +5 more
Aug 2, 2021
Conjunctivitis, Bacterial, Keratitis Bacterial Trial in San Francisco (Dunk, Exposure to Hot Tub)
Completed
- Conjunctivitis, Bacterial
- Keratitis Bacterial
- Dunk
- Exposure to Hot Tub
-
San Francisco, CaliforniaUCSF
Sep 2, 2020
Bacterial Conjunctivitis Trial in Worldwide (SHP640, PVP-I 0.6%, Placebo)
Conjunctivitis, Conjunctivitis, Bacterial Trial in Guadalajara (PRO-174, Sophixín Ofteno®)
Completed
- Conjunctivitis
- Conjunctivitis, Bacterial
- PRO-174
- Sophixín Ofteno®
-
Guadalajara, Jalisco, MexicoPrivate Medical Offices
Oct 2, 2019
Bacterial Conjunctivitis Trial in Downey, Rajajinagar (Gatifloxacin 0.5% eye drops, eye drops)
Completed
- Bacterial Conjunctivitis
- Gatifloxacin 0.5% eye drops
- placebo eye drops
-
Downey, California
- +1 more
Apr 10, 2019
Bacterial Conjunctivitis Trial in Guadalajara (PRO-157, Vigamox, Zymar®)
Completed
- Bacterial Conjunctivitis
- PRO-157
- +3 more
-
Guadalajara, Jalisco, MexicoUnidad Medica "Grupo Pediátrico"
May 8, 2019
Ligneous Conjunctivitis Trial in Indianapolis, Florence, Padova (Human Plasminogen)
Completed
- Ligneous Conjunctivitis
- Human Plasminogen
-
Indianapolis, Indiana
- +2 more
Jan 2, 2023
Bacterial Conjunctivitis Trial in United States (Vancomycin 1.1%, Placebo)
Completed
- Bacterial Conjunctivitis
- Vancomycin 1.1%
- Placebo
-
Paramount, California
- +15 more
Feb 12, 2019
Plasminogen Deficiency Trial in Saskatoon (Aliquoted allogeneic donor plasma in patient's conjunctiva)
Not yet recruiting
- Plasminogen Deficiency
- Aliquoted allogeneic donor plasma in patient's conjunctiva
-
Saskatoon, Saskatchewan, CanadaUniversity of Saskatchewan
Nov 7, 2022
Conjunctivitis, Bacterial Trial in Guadalajara (PRO-143 Ophthalmic Solution)
Withdrawn
- Conjunctivitis, Bacterial
- PRO-143 Ophthalmic Solution
-
Guadalajara, Jalisco, MexicoIndependent Clinical Research Center
Oct 8, 2018
Neonatal SEPSIS Trial in Nanoro, Banjul (Azithromycin, Placebo Oral Tablet)
Completed
- Neonatal SEPSIS
- Azithromycin
- Placebo Oral Tablet
-
Nanoro, Burkina Faso
- +1 more
Mar 15, 2022
Allergic Conjunctivitis Trial in Andover (TL-925, Placebo)
Recruiting
- Allergic Conjunctivitis
- TL-925
- Placebo
-
Andover, MassachusettsAndover Eye Associates
Nov 29, 2023
Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)
Recruiting
- Allergic Conjunctivitis
- MDI-1228_mesylate Ophthalmic Solution
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jul 24, 2023
Conjunctivitis in Setting of DUPIXENT® Treatment for Atopic
Active, not recruiting
- Conjunctivitis
- Atopic Dermatitis
-
Irvine, California
- +14 more
Jul 8, 2022
Mpox in HIV Negative High Risk Sexual Health Clinic Attenders
Not yet recruiting
- Monkeypox
- HIV Coinfection
- No intervention
- (no location specified)
Jul 19, 2023
Allergic Conjunctivitis Trial in Taichung (Vitamin D, Placebo)
Recruiting
- Allergic Conjunctivitis
- Vitamin D
- Placebo
-
Taichung, TaiwanChina Medical University Hospital
May 1, 2023
Seasonal Allergic Conjunctivitis Trial in Andover, Memphis (Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic
Not yet recruiting
- Seasonal Allergic Conjunctivitis
- Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution
- +3 more
-
Andover, Massachusetts
- +1 more
Nov 9, 2022
Diabetic Macular Edema Trial in Glostrup (Dexamethasone nanoparticles eye drops)
Completed
- Diabetic Macular Edema
- Dexamethasone nanoparticles eye drops
-
Glostrup, DenmarkGlostrup Hospital
Jun 7, 2022
HIV Trial in Worldwide (Nevirapine, Nevirapine )
Completed
- HIV Infections
- Nevirapine
- Nevirapine placebo
-
Umlazi, KwaZulu-Natal, South Africa
- +4 more
Jul 25, 2022
Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,
Not yet recruiting
- Allergic Conjunctivitis
- Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
- +3 more
-
Phoenix, Arizona
- +2 more
Nov 9, 2022
Allergic Conjunctivitis Trial in Andover (PRT-2761 0.5%, PRT-2761 1%, Patanol)
Completed
- Allergic Conjunctivitis
- PRT-2761 0.5%
- +4 more
-
Andover, MassachusettsAndover Eye Associates
Oct 13, 2022
Allergic Conjunctivitis, Allergic Rhinitis Trial in Vienna (Eye Drops, Solution in Single-Dose Container)
Completed
- Allergic Conjunctivitis
- Allergic Rhinitis
- Eye Drops, Solution in Single-Dose Container
-
Vienna, AustriaVienna Challenge Chamber
Aug 24, 2022
Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of
Completed
- Conjunctivitis, Allergic
- ADX-102 Ophthalmic Drops (0.5%)
- +2 more
-
Morrow, Georgia
- +4 more
Dec 14, 2022